Legit is an industry-leading marketplace that connects companies with experts in life sciences via secure messages. Founded in 2012 and headquartered in the United States, Legit™ is a game-changer in the fields of Biotechnology, Pharmaceutical, and SaaS.
Their suite of products for businesses in life sciences aims to increase efficiencies across drug design, medical device development, and external alliances. With over 2 million experts, Legit™ allows businesses to discover and connect with precise experts on any niche topic.
In April 2018, Legit™ secured a significant $2.60M Seed Round investment from notable investors such as Clocktower Ventures, Eniac Ventures, Expansion Venture Capital, Max Ventures, Cantos Ventures, and Elementum Ventures.
Legit's innovative approach to connecting companies with experts and their impressive growth potential make them a compelling investment opportunity in the life sciences marketplace.